Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease

PHASE2TerminatedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

January 31, 2010

Conditions
Alzheimer's Disease
Interventions
DRUG

PRX-03140

DRUG

Donepezil

DRUG

Placebo

Trial Locations (33)

10029

The Mount Sinai Medical Center, New York

10305

Behavioral Medical Research of Staten Island, Staten Island

11235

Social Psychiatry Research Institute, Brooklyn

23185

The Center for Excellence in Aging and Geriatric Health, Williamsburg

23507

The Glennan Center for Geriatrics & Gerontology, Eastern Virginia Medical School, Norfolk

28204

The Neurological Institute, P.A., Charlotte

28655

MedArk, Morgantown

32216

Clinical Neuroscience Solutions, Inc., Jacksonville

32806

Compass Research, Orlando

33317

Berma Research Group, Plantation

33445

Brain Matters Research, Delray Beach

33613

Stedman Clinical Trials, Tampa

33617

Roskamp Institute, Tampa

33709

Meridien Research, St. Petersburg

34205

Bradenton Research Center, Bradenton

42003

Four Rivers Clinical Research, Paducah

43623

Neurology and Neuroscience Center of Ohio, Toledo

71104

J. Gary Booker, MD, APMC, Shreveport

74104

Tulsa Clinical Research, LLC, Tulsa

77063

Todd Swick, MD, PA, Houston

85013

Barrow Neurological Institute, Phoenix

85050

PsyPharma Clinical Research, Inc., Phoenix

90505

Torrance Clinical Research, Torrance

91403

California Neuroscience Research Medical Group, Inc., Sherman Oaks

91950

Synergy Clinical Research Center, National City

93030

Pacific Neuroscience Medical Group, Oxnard

85741-3537

Northwest NeuroSpecialists, PLLC, Tucson

04074

Maine Neurology, Scarborough

02062

The ICPS Group, Norwood

08759

Alzheimer's Research Corporation, Paterson

08540

Global Medical Institutes, Princeton

02914

Rhode Island Mood and Memory Research Institute, East Providence

05201

The Memory Clinic, Bennington

Sponsors
All Listed Sponsors
lead

Epix Pharmaceuticals, Inc.

INDUSTRY